Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence

Sara E. Pinney, Jennifer M. Oliver-Krasinski, Linda Ernst, Nkecha Hughes, Puja Patel, Doris A. Stoffers, Pierre Russo, Diva D. De León

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: The aim was to describe the clinical presentation and to characterize the genetic mutation present in a child with congenital malabsorptive diarrhea and neonatal diabetes. Research Design and Methods: Clinical data were obtained from chart review. Histopathological characterization of intestinal samples and neurogenin-3 (NEUROG3) sequencing were performed. Expression and function of the mutated NEUROG3 protein were assessed by Western blot analysis and luciferase reporter assay. Results: At birth, the proband was small for gestational age. She presented for evaluation with persistent diarrhea and a poor postnatal growth pattern. Although the pancreas was present, serum amylase and fecal elastase levels were decreased, and blood glucose levels were persistently elevated by 5 months of age. Immunostaining of a small intestine biopsy for chromogranin A demonstrated complete absence of neuroendocrine cells. Genetic analysis revealed a nonsense mutation (E123X) in the region encoding helix II of the NEUROG3 gene, leading to premature termination at amino acid 123. The mutated truncated NEUROG3 protein was identified by Western blot analysis. Reporter assays show decreased transactivation of the NEUROD1 promoter by mutant NEUROG3 protein as compared to wild type. Conclusions: This report describes a newly identified nonsense mutation in human NEUROG3 that in the homozygous state is associated with neonatal diabetes and malabsorptive diarrhea.

Original languageEnglish (US)
Pages (from-to)1960-1965
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume96
Issue number7
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Medical problems
Diarrhea
Genes
Nonsense Codon
Mutation
Assays
Western Blotting
Chromogranin A
Neuroendocrine Cells
Proteins
Biopsy
Pancreatic Elastase
Amylases
Luciferases
Transcriptional Activation
Gestational Age
Small Intestine
Blood Glucose
Pancreas
Research Design

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence. / Pinney, Sara E.; Oliver-Krasinski, Jennifer M.; Ernst, Linda; Hughes, Nkecha; Patel, Puja; Stoffers, Doris A.; Russo, Pierre; De León, Diva D.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 96, No. 7, 01.07.2011, p. 1960-1965.

Research output: Contribution to journalArticle

Pinney, Sara E. ; Oliver-Krasinski, Jennifer M. ; Ernst, Linda ; Hughes, Nkecha ; Patel, Puja ; Stoffers, Doris A. ; Russo, Pierre ; De León, Diva D. / Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence. In: Journal of Clinical Endocrinology and Metabolism. 2011 ; Vol. 96, No. 7. pp. 1960-1965.
@article{3476ec6a57594598a12af28d50891574,
title = "Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence",
abstract = "Objective: The aim was to describe the clinical presentation and to characterize the genetic mutation present in a child with congenital malabsorptive diarrhea and neonatal diabetes. Research Design and Methods: Clinical data were obtained from chart review. Histopathological characterization of intestinal samples and neurogenin-3 (NEUROG3) sequencing were performed. Expression and function of the mutated NEUROG3 protein were assessed by Western blot analysis and luciferase reporter assay. Results: At birth, the proband was small for gestational age. She presented for evaluation with persistent diarrhea and a poor postnatal growth pattern. Although the pancreas was present, serum amylase and fecal elastase levels were decreased, and blood glucose levels were persistently elevated by 5 months of age. Immunostaining of a small intestine biopsy for chromogranin A demonstrated complete absence of neuroendocrine cells. Genetic analysis revealed a nonsense mutation (E123X) in the region encoding helix II of the NEUROG3 gene, leading to premature termination at amino acid 123. The mutated truncated NEUROG3 protein was identified by Western blot analysis. Reporter assays show decreased transactivation of the NEUROD1 promoter by mutant NEUROG3 protein as compared to wild type. Conclusions: This report describes a newly identified nonsense mutation in human NEUROG3 that in the homozygous state is associated with neonatal diabetes and malabsorptive diarrhea.",
author = "Pinney, {Sara E.} and Oliver-Krasinski, {Jennifer M.} and Linda Ernst and Nkecha Hughes and Puja Patel and Stoffers, {Doris A.} and Pierre Russo and {De Le{\'o}n}, {Diva D.}",
year = "2011",
month = "7",
day = "1",
doi = "10.1210/jc.2011-0029",
language = "English (US)",
volume = "96",
pages = "1960--1965",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence

AU - Pinney, Sara E.

AU - Oliver-Krasinski, Jennifer M.

AU - Ernst, Linda

AU - Hughes, Nkecha

AU - Patel, Puja

AU - Stoffers, Doris A.

AU - Russo, Pierre

AU - De León, Diva D.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Objective: The aim was to describe the clinical presentation and to characterize the genetic mutation present in a child with congenital malabsorptive diarrhea and neonatal diabetes. Research Design and Methods: Clinical data were obtained from chart review. Histopathological characterization of intestinal samples and neurogenin-3 (NEUROG3) sequencing were performed. Expression and function of the mutated NEUROG3 protein were assessed by Western blot analysis and luciferase reporter assay. Results: At birth, the proband was small for gestational age. She presented for evaluation with persistent diarrhea and a poor postnatal growth pattern. Although the pancreas was present, serum amylase and fecal elastase levels were decreased, and blood glucose levels were persistently elevated by 5 months of age. Immunostaining of a small intestine biopsy for chromogranin A demonstrated complete absence of neuroendocrine cells. Genetic analysis revealed a nonsense mutation (E123X) in the region encoding helix II of the NEUROG3 gene, leading to premature termination at amino acid 123. The mutated truncated NEUROG3 protein was identified by Western blot analysis. Reporter assays show decreased transactivation of the NEUROD1 promoter by mutant NEUROG3 protein as compared to wild type. Conclusions: This report describes a newly identified nonsense mutation in human NEUROG3 that in the homozygous state is associated with neonatal diabetes and malabsorptive diarrhea.

AB - Objective: The aim was to describe the clinical presentation and to characterize the genetic mutation present in a child with congenital malabsorptive diarrhea and neonatal diabetes. Research Design and Methods: Clinical data were obtained from chart review. Histopathological characterization of intestinal samples and neurogenin-3 (NEUROG3) sequencing were performed. Expression and function of the mutated NEUROG3 protein were assessed by Western blot analysis and luciferase reporter assay. Results: At birth, the proband was small for gestational age. She presented for evaluation with persistent diarrhea and a poor postnatal growth pattern. Although the pancreas was present, serum amylase and fecal elastase levels were decreased, and blood glucose levels were persistently elevated by 5 months of age. Immunostaining of a small intestine biopsy for chromogranin A demonstrated complete absence of neuroendocrine cells. Genetic analysis revealed a nonsense mutation (E123X) in the region encoding helix II of the NEUROG3 gene, leading to premature termination at amino acid 123. The mutated truncated NEUROG3 protein was identified by Western blot analysis. Reporter assays show decreased transactivation of the NEUROD1 promoter by mutant NEUROG3 protein as compared to wild type. Conclusions: This report describes a newly identified nonsense mutation in human NEUROG3 that in the homozygous state is associated with neonatal diabetes and malabsorptive diarrhea.

UR - http://www.scopus.com/inward/record.url?scp=79960108667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960108667&partnerID=8YFLogxK

U2 - 10.1210/jc.2011-0029

DO - 10.1210/jc.2011-0029

M3 - Article

C2 - 21490072

AN - SCOPUS:79960108667

VL - 96

SP - 1960

EP - 1965

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -